Illuminating
and Healing
Your Mind
Illuminating and healing your mind

At NeonMind Biosciences, we believe in “mind over matter”.

We plan to help people change their lives by changing their minds, through treatment with psychedelics.

01Our Focus

Psilocybin based treatments

Our first step is tackling one of the biggest health issues the world is facing right now: obesity.

Obesity accounts for
37%
of the global burden of disease.

NeonMind is exploring psilocybin (found in psychedelic mushrooms) as an innovative treatment approach to weight loss through a preclinical trial.

We know that psilocybin is known to activate serotonin receptors, and that serotonin can curb cravings, shut off appetite, and reduce eating.

Learn More

02News

December 2, 2021

NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference

November 23, 2021

NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001

November 17, 2021

NeonMind to Participate in Panel Discussion at Lift & Co. Expo’s Psychedelics Business Summit on November 19, 2021

More News

03Team

Scientific and Advisory

x
x
x

Management and Board

x
x
x

04Contact Us

Questions, Comments & Inquiries

We’d love to hear from you.

Please fill out the form below to submit a question, join our mailing list or request more information about the company.

Corporate Head Office
Investor Relations

KCSA Strategic Communications

neonmind@kcsa.com

Tel: 1-866-318-6874

Transfer Agent

Endeavor Trust Corporation
david@endeavortrust.com
604-559-8908

Media Inquiries

KCSA Strategic Communications

Annie Graf

neonmind@kcsa.com

Tel: 786-390-2644